Brendan Floyd

Dr. Brendan Floyd

Pediatrics, Stanford University School of Medicine, Stanford, California, USA
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Molecular Cell
Verified
Journal Article
Closed access
Brendan FloydBrendan Floyd
Brendan Floyd
EWEmily M. Wilkerson
Emily M. Wilkerson
MVMike T. Veling
Mike T. Veling
CMCatie E. Minogue
Catie E. Minogue
CXChuanwu Xia
Chuanwu Xia
DPDavid J. Pagliarini
David J. Pagliarini

1 August 2016 in Molecular Cell
Verified
Journal Article
Closed access
JSJonathan A. Stefely
Jonathan A. Stefely
FLFloriana Licitra
Floriana Licitra
LLLeila Laredj
Leila Laredj
ARAndrew G. Reidenbach
Andrew G. Reidenbach
ZKZachary A. Kemmerer
Zachary A. Kemmerer
DPDavid J. Pagliarini
David J. Pagliarini

1 January 2015 in Molecular Cell
Verified
Journal Article
Closed access
JSJonathan A. Stefely
Jonathan A. Stefely
ARAndrew G. Reidenbach
Andrew G. Reidenbach
AUArne Ulbrich
Arne Ulbrich
KOKrishnadev Oruganty
Krishnadev Oruganty
Brendan FloydBrendan Floyd
Brendan Floyd
DPDavid J. Pagliarini
David J. Pagliarini

1 September 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ASAmelia J Still
Amelia J Still
Brendan FloydBrendan Floyd
Brendan Floyd
AHAlexander S Hebert
Alexander S Hebert
CBCraig A Bingman
Craig A Bingman
JCJoshua J Carson
Joshua J Carson
DPDavid J Pagliarini
David J Pagliarini
Lysine acetylation is rapidly becoming established as a key post-translational modification for regulating mitochondrial metabolism. Nonetheless, distinguishing regulatory sites from among the thousands identified by mass spectrometry and elucidating how these modifications alter enzyme function remain primary challenges. Here, we performed multiplexed quantitative mass spectrometry to measure changes in the mouse liver mitochondrial acetylproteome in response to acute and chronic alterations in nutritional status, and integrated these data sets with our compendium of predicted Sirt3 targets. These analyses highlight a subset of mitochondrial proteins with dynamic acetylation sites, including acetyl-CoA acetyltransferase 1 (Acat1), an enzyme central to multiple metabolic pathways. We performed in vitro biochemistry and molecular modeling to demonstrate that acetylation of Acat1 decreases its activity by disrupting the binding of coenzyme A. Collectively, our data reveal an important new target of regulatory acetylation and provide a foundation for investigating the role of select mitochondrial protein acetylation sites in mediating acute and chronic metabolic transitions.

26 August 2014 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Melkam Alamerew KebedeMelkam Alamerew Kebede
Melkam Alamerew Kebede
AOAngie T. Oler
Angie T. Oler
TGTrillian Gregg
Trillian Gregg
ABAllison J. Balloon
Allison J. Balloon
AJAdam Johnson
Adam Johnson
AAAlan D. Attie
Alan D. Attie
We previously positionally cloned Sorcs1 as a diabetes quantitative trait locus. Sorcs1 belongs to the Vacuolar protein sorting-10 (Vps10) gene family. In yeast, Vps10 transports enzymes from the trans-Golgi network (TGN) to the vacuole. Whole-body Sorcs1 KO mice, when made obese with the leptinob mutation (ob/ob), developed diabetes. β Cells from these mice had a severe deficiency of secretory granules (SGs) and insulin. Interestingly, a single secretagogue challenge failed to consistently elicit an insulin secretory dysfunction. However, multiple challenges of the Sorcs1 KO ob/ob islets consistently revealed an insulin secretion defect. The luminal domain of SORCS1 (Lum-Sorcs1), when expressed in a β cell line, acted as a dominant-negative, leading to SG and insulin deficiency. Using syncollin-dsRed5TIMER adenovirus, we found that the loss of Sorcs1 function greatly impairs the rapid replenishment of SGs following secretagogue challenge. Chronic exposure of islets from lean Sorcs1 KO mice to high glucose and palmitate depleted insulin content and evoked an insulin secretion defect. Thus, in metabolically stressed mice, Sorcs1 is important for SG replenishment, and under chronic challenge by insulin secretagogues, loss of Sorcs1 leads to diabetes. Overexpression of full-length SORCS1 led to a 2-fold increase in SG content, suggesting that SORCS1 is sufficient to promote SG biogenesis.

1 April 2020 in Cell Metabolism
Verified
Journal Article
Closed access
ASAndrew Y. Sung
Andrew Y. Sung
Brendan FloydBrendan Floyd
Brendan Floyd
DPDavid J. Pagliarini
David J. Pagliarini